Search Within

Han Xiao

  1. "Head and Neck Service"
Formats
  1. Journal Article (7)
  2. Meeting Abstract (6)
Groups
  1. Department of Medicine (13)
  2. Genitourinary Oncology Service (13)
  3. Head and Neck Service (13)
  4. Solid Tumor Oncology Division (13)
  5. Neuroradiology Service (10)
  6. Radiology, Department of (10)

More Groups

People
  1. Eric Sherman (13)
  2. David Pfister (12)
  3. Matthew Fury (11)
  4. Sofia Haque (10)
  5. Alan Ho (9)
  6. Shrujal Baxi (8)

More People

Years
  1. 2020 (1)
  2. 2018 (1)
  3. 2017 (2)
  4. 2016 (2)
  5. 2015 (1)
  6. 2014 (2)

More Years

Publications
  1. Journal of Clinical Oncology (6)
  2. Head & Neck (2)
  3. Annals of Oncology (1)
  4. Cancer (1)
  5. International Journal of Radiation Oncology, Biology, Physics (1)
  6. Investigational New Drugs (1)

More Publications

Publishers
  1. American Society of Clinical Oncology (6)
  2. John Wiley & Sons, Inc. (2)
  3. Elsevier Inc. (1)
  4. Harborside Press (1)
  5. Oxford University Press (1)
  6. Springer (1)

More Publishers

Results (13)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • A phase 1b study of cetuximab and BYL719 (alpelisib) concurrent with intensity modulated radiation therapy in stage III-IVB head and neck squamous cell carcinoma
    Journal Article

    Dunn, L. A.; Riaz, N.; Fury, M. G.; McBride, S. M.; Michel, L.; Lee, N. Y.; Sherman, E. J.; Baxi, S. S.; Haque, S. S.; Katabi, N.; more...
    International Journal of Radiation Oncology, Biology, Physics (2020)

    Fulltext@MSK | Save
  • Long-term quality of life in older patients with HPV-related oropharyngeal cancer
    Journal Article

    Baxi, S. S.; Cullen, G.; Xiao, H.; Atoria, C. L.; Sherman, E. J.; Ho, A.; Lee, N. Y.; Elkin, E. B.; Pfister, D. G.
    Head & Neck (2018)

    Fulltext@MSK | Save
  • Phase Ib study of cetuximab + BYL719 + IMRT in stage III-IVB head and neck squamous cell carcinoma (HNSCC)
    Meeting Abstract

    Dunn, L.; Riaz, N.; Baxi, S. S.; McBride, S. M.; Sherman, E. J.; Michel, L.; Haque, S.; Katabi, N.; Wong, R. J.; Xiao, H.; more...
    Journal of Clinical Oncology (2017)

    Fulltext@MSK | Save
  • A phase II study of temsirolimus added to low-dose weekly carboplatin and paclitaxel for patients with recurrent and/or metastatic (R/M) head and neck squamous cell carcinoma (HNSCC)
    Journal Article

    Dunn, L. A.; Fury, M. G.; Xiao, H.; Baxi, S. S.; Sherman, E. J.; Korte, S.; Pfister, C.; Haque, S.; Katabi, N.; Ho, A. L.; more...
    Annals of Oncology (2017)

    Fulltext@MSK | Save
  • Proton radiotherapy for incurable recurrent or metastatic cancers of the head and neck by the RTOG 8502 hypofractionated palliative schedule
    Meeting Abstract

    Lok, B. H.; Zong, J.; Gutinov, S. I.; Cai, X.; Deselm, C.; Romesser, P. B.; Lanning, R. M.; Shcherba, M.; Xiao, H.; Sherman, E. J.; more...
    Journal of Clinical Oncology (2016)

    Fulltext@MSK | Save
  • Phase II trial of bevacizumab + cetuximab + cisplatin with concurrent intensity-modulated radiation therapy for patients with stage III/IVB head and neck squamous cell carcinoma
    Journal Article

    Fury, M. G.; Xiao, H.; Sherman, E. J.; Baxi, S.; Smith-Marrone, S.; Schupak, K.; Gewanter, R.; Gelblum, D.; Haque, S.; Schoder, H.; more...
    Head & Neck (2016)

    Fulltext@MSK | Save
  • Employment and quality of life (QOL) in human papillomavirus-related (HPV+) oropharynx cancer treated with definitive chemoradiation (CTRT)
    Meeting Abstract

    Baxi, S. S.; Xiao, H.; Fury, M. G.; Atoria, C. L.; Dunn, L.; Salz, T.; Sherman, E. J.; Ho, A. L.; Lee, N. Y.; Pfister, D. G.
    Journal of Clinical Oncology (2015)

    Fulltext@MSK | Save
  • A phase II trial of temsirolimus plus low-dose weekly carboplatin and paclitaxel for recurrent/metastatic HNSCC
    Meeting Abstract

    Fury, M. G.; Xiao, H.; Baxi, S. S.; Sherman, E. J.; Smith-Marrone, S.; Ho, A. L.; Sima, C. S.; Nwankwo, O. G.; Haque, S.; Katabi, N.; more...
    Journal of Clinical Oncology (2014)

    Fulltext@MSK | Save
  • A phase II study of pralatrexate with vitamin B12 and folic acid supplementation for previously treated recurrent and/or metastatic head and neck squamous cell cancer
    Journal Article

    Ho, A. L.; Lipson, B. L.; Sherman, E. J.; Xiao, H.; Fury, M. G.; Apollo, A.; Seetharamu, N.; Sima, C. S.; Haque, S.; Lyo, J. K.; more...
    Investigational New Drugs (2014)

    Fulltext@MSK | Save
  • A phase 1 study of everolimus plus docetaxel plus cisplatin as induction chemotherapy for patients with locally and/or regionally advanced head and neck cancer
    Journal Article

    Fury, M. G.; Sherman, E.; Ho, A. L.; Xiao, H.; Tsai, F.; Nwankwo, O.; Sima, C.; Heguy, A.; Katabi, N.; Haque, S.; more...
    Cancer (2013)

    Fulltext@MSK | Save